Bacchus Bio innovation Co., Ltd.
PrivateLast Round
Strategic
Oct 24, 2025
Total Funding Raised
$11.28M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Bacchus Bio innovation Co., Ltd. operates in Healthcare & Life Sciences and is based in Kobe. Its latest recorded funding round was a Strategic round in October 2025.
Bacchus Bio innovation Co., Ltd. is a biotechnology company that operates an integrated biofoundry platform for the development and production of useful substances using synthetic biology and digital technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Smart Manufacturing, Clean Manufacturing, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bacchus Bio innovation Co., Ltd. Comparables
Compare Bacchus Bio innovation Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CynosBio, Inc. | 78% | |
| BDI Biotech | 76% | |
| Logomix Biotechnology, Inc. | 76% |
For institutional investors. Book with your work email.
Bacchus Bio innovation Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Oct 24, 2025 | ||||
| Strategic | Mar 16, 2025 | ||||
| Strategic | Nov 1, 2024 | ||||
| Strategic | Jul 17, 2024 | ||||
| Strategic | May 17, 2023 | ||||
Strategic | Nov 30, 2021 |
For institutional investors. Book with your work email.
Bacchus Bio innovation Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alliance Forum Foundation | Seed |
| DEFTA Partners | Seed, Series A |
| Science and Technology Entrepreneurship Co., Ltd. | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 24, 2025
Mizuho Bank, Ltd. participated in the round.
- Mar 16, 2025
Nippon Soda Co., Ltd. participated in the round.
For institutional investors. Book with your work email.
Bacchus Bio innovation Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bacchus Bio innovation Co., Ltd.'s valuation, stock price, and market status.
Is Bacchus Bio innovation Co., Ltd. a public or private company?
Bacchus Bio innovation Co., Ltd. is a private company.
What is the current stock price of Bacchus Bio innovation Co., Ltd.?
Bacchus Bio innovation Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Bacchus Bio innovation Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bacchus Bio innovation Co., Ltd. worth (valuation)?
Valuation information for Bacchus Bio innovation Co., Ltd. is not publicly available.
Can I buy Bacchus Bio innovation Co., Ltd. stock?
Bacchus Bio innovation Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bacchus Bio innovation Co., Ltd.'s last funding round?
Bacchus Bio innovation Co., Ltd.'s most recent funding round was Strategic on October 24, 2025.
Who are the main investors in Bacchus Bio innovation Co., Ltd.?
Key investors in Bacchus Bio innovation Co., Ltd. include Alliance Forum Foundation, DEFTA Partners, Science and Technology Entrepreneurship Co., Ltd..
Will Bacchus Bio innovation Co., Ltd. IPO soon?
No public IPO plans have been announced for Bacchus Bio innovation Co., Ltd..
How can I track Bacchus Bio innovation Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Bacchus Bio innovation Co., Ltd.'s shares on secondary markets.